Inge Marie Svane
Clinical Professor
- 2017
- Published
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
Ascierto, P. A., Del Vecchio, M., Robert, C., Mackiewicz, A., Chiarion-Sileni, V., Arance, A., Lebbé, C., Bastholt, L., Hamid, O., Rutkowski, P., McNeil, C., Garbe, C., Loquai, C., Dreno, B., Thomas, L., Grob, J-J., Liszkay, G., Nyakas, M., Gutzmer, R., Pikiel, J. & 10 others, , May 2017, In: Lancet Oncology. 18, 5, p. 611-622 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
Bjoern, J., Lyngaa, R., Andersen, R., Hølmich, Lisbet Rosenkrantz, Hadrup, S. R., dqp123, dqp123 & Svane, Inge Marie, 2017, In: OncoTarget. 8, 16, p. 27062-27074Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Buschow, S. I., Ramazzotti, M., Reinieren-Beeren, I. M. J., Heinzerling, L. M., Westdorp, H., Stefanini, I., Beltrame, L., Hato, S. V., Ellebaek, E., Gross, S., Nguyen, V. A., Weinlich, G., Ragoussis, J., Baban, D., Schuler-Thurner, B., Svane, I. M., Romani, N., Austyn, J. M., De Vries, I. J. M., Schuler, G. & 2 others, , 2017, In: OncoTarget. 8, 40, p. 67439-67456 18 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, , 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cancer immunotherapy in patients with preexisting autoimmune disorders
dqp123, dqp123, Pedersen, M. & Svane, Inge Marie, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 333-337 5 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer
dqp123, dqp123, Kjeldsen, J. W., Andersen, R., Westergaard, M. C. W., Bianchi, V., Legut, M., Attaf, M., Szomolay, B., Ott, S., Dolton, G., Lyngaa, R., Hadrup, S. R., Sewell, A. K. & Svane, Inge Marie, 2017, In: Clinical Cancer Research. 23, 19, p. 5779-5788Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials
dqp123, dqp123, Kimper-Karl, M. L., Høyer, K. L., Bastholt, L., Schmidt, H. & Svane, Inge Marie, 2017, In: European Journal of Cancer. 74, p. 89-95Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, Özcan, Martinenaite, E., Riley, C., Straten, P., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: Leukemia. 31, p. 495-498Research output: Contribution to journal › Letter › Research › peer-review
- Published
Predictors of responses to immune checkpoint blockade in advanced melanoma
Jacquelot, N., Roberti, M. P., Enot, D. P., Rusakiewicz, S., Ternès, N., Jegou, S., Woods, D. M., Sodré, A. L., Hansen, M., Meirow, Y., Sade-Feldman, M., Burra, A., Kwek, S. S., Flament, C., Messaoudene, M., Duong, C. P. M., Chen, L., Kwon, B. S., Anderson, A. C., Kuchroo, V. K. & 30 others, , 2017, In: Nature Communications. 8, 13 p., 592.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
Jespersen, H., Lindberg, M. F., dqp123, dqp123, Söderberg, E. M. V., Andersen, R., Keller, U., Ny, L., Svane, Inge Marie, Nilsson, L. M. & Nilsson, J. A., 2017, In: Nature Communications. 8, 10 p., 707.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4054758
Most downloads
-
277
downloads
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
257
downloads
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
183
downloads
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Research output: Contribution to journal › Journal article › Research › peer-review
Published